Petros Pharmaceuticals, Inc. (OTCPK: PTPI)
Health Care · Pharmaceuticals · US
$0.00
+57.41% today · -86.3% 1Y
Petros Pharmaceuticals, Inc. (OTCPK: PTPI) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $180.08K and employs 3 people.
Over the last twelve months the share price has lost 86.3%, trading between 0.00 and 0.03.
Tweenvest scores Petros Pharmaceuticals, Inc. across four factors: quality 27/100. Its strongest factor is quality.
PTPI price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $180.08K
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.39
- Dividend yield
- —
- Beta (5Y)
- 1.92
- 52-week high
- $0.03
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 42.37M
- Employees
- 3
- Next earnings
- —
About Petros Pharmaceuticals, Inc.
Petros Pharmaceuticals, Inc. is a pharmaceutical company dedicated to male health solutions. Their activities include both the commercialization and ongoing development of Stendra, a prescription PDE-5 inhibitor specifically designed for treating erectile dysfunction (ED). Furthermore, Petros is advancing H100, a proprietary topical formulation currently in development as a potential treatment for acute Peyronie's disease. The company's offerings also extend to a range of erectile dysfunction products, such as vacuum erection devices. Petros Pharmaceuticals, Inc. operates from its base in New York, New York.
- ISIN
- US71678J3086
- Listed since
- Dec 2, 2020
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,233.66 | -1.06% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.14 | +0.04% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $156.45 | +3.84% |
| Roche Holding AGSWX: ROP | $368.80B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.57 | +2.15% |
Figures last refreshed Aug 18, 2026.